{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:23:55Z","timestamp":1762867435417,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T00:00:00Z","timestamp":1526860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000918","name":"The New York Community Trust","doi-asserted-by":"crossref","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000918","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ajoc.2018.05.007","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T13:45:44Z","timestamp":1527169544000},"page":"49-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Treatment of juxtapapillary hemangioblastoma by intra-arterial (ophthalmic artery) chemotherapy with bevacizumab"],"prefix":"10.1016","volume":"11","author":[{"given":"Jasmine H.","family":"Francis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason S.","family":"Slakter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Abramson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Odrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. Pierre","family":"Gobin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajoc.2018.05.007_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.oret.2016.08.004","article-title":"Laser photocoagulation for peripheral retinal capillary hemangioblastoma in von Hippel-Lindau disease","volume":"1","author":"Krivosic","year":"2017","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"10.1016\/j.ajoc.2018.05.007_bib2","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/IAE.0000000000000254","article-title":"Therapeutic outcomes of retinal hemangioblastomas","volume":"34","author":"Kim","year":"2014","journal-title":"Retina (Philadelphia, Pa)"},{"issue":"8","key":"10.1016\/j.ajoc.2018.05.007_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.oftal.2014.01.007","article-title":"Oral propranolol and intravitreal ranibizumab for refractory serous macular detachment secondary to retinal capillary hemangioblastoma","volume":"90","author":"Hern\u00e1ndez-Mart\u00ednez","year":"2015","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"5","key":"10.1016\/j.ajoc.2018.05.007_bib4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/jamaophthalmol.2013.4696","article-title":"Retinal hemangioblastoma regression after single session of photodynamic therapy","volume":"132","author":"Caminal","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajoc.2018.05.007_bib5","series-title":"Retina","first-page":"2156","article-title":"Capillary Hemangioblastoma of the retina and von Hippel\u2013Lindau disease","author":"Chew","year":"2013"},{"issue":"3","key":"10.1016\/j.ajoc.2018.05.007_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archopht.117.3.371","article-title":"Clinical characteristics of ocular angiomatosis in von hippel-lindau disease and correlation with germline mutation","volume":"117","author":"Webster","year":"1999","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajoc.2018.05.007_bib7","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archophthalmol.2011.5","article-title":"Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience","volume":"129","author":"Gobin","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2018.05.007_bib8","first-page":"145","article-title":"Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma","volume":"8","author":"Riina","year":"2009","journal-title":"J Exp Therapeut Oncol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993618300999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993618300999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:57:32Z","timestamp":1762527452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993618300999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":8,"alternative-id":["S2451993618300999"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2018.05.007","relation":{},"ISSN":["2451-9936"],"issn-type":[{"type":"print","value":"2451-9936"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of juxtapapillary hemangioblastoma by intra-arterial (ophthalmic artery) chemotherapy with bevacizumab","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2018.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}